Merck stock trades steady as oncology pipeline and Keytruda revenue underpin valuation

Merck stock trades steady as oncology pipeline and Keytruda revenue underpin valuation  Ad-hoc-news.de

Summary aggregated from Ad-hoc-news.de's public RSS feed. The full reporting belongs to Ad-hoc-news.de — please read it on their site.